Clinical Trial Update: Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the safety and efficacy of eletriptan for migraine in patients not adequately treated with NSAIDs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Eletriptan (eletriptan)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Migraine | Phase 4 | Status: COMPLETED